1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Patient details and outcome data
Sex Age (yr) Cement Volume Injected (mL) Primary Disease Pain Preprocedure (VAS) Pain 1 Month Postprocedure (VAS) Female 36 14 Breast carcinoma 4 0 Male 59 11 Myeloma 7 2 Female 62 12 Non-small cell lung carcinoma 7 0 Male 66 25 Myeloma 5 0 Male 86 10 Osteoporosis 7 0 Female 69 10 Osteoporosis 10 6 Female 69 10 Breast carcinoma 8 4 Female 77 11 Osteoporosis 7 3 Female 75 11 Myeloma 7 0 Male 76 8 Non-small cell lung carcinoma 8 0
Note:—VAS indicates Visual Analog Scale.